1080950

Mezgebe Berhe, MD — FEI 3013631687

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 14, 2018
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Dallas, TX (United States)

Additional Details

Clinical Investigator (CI)